Received 10 Karmas
Received 0 Karma

[TimAlerts] Agree with Chicago. Keep in mind $EXAS had bad guidance... guidance matters more than the earnings. Plus they are up a ton year to date, and biotechs in general are getting hammered. Look at PRQR today. Had good data, but gave up all of its gains.
Received 0 Karma
Received 0 Karma
Received 0 Karma
Received 0 Karma
Received 0 Karma
Received 0 Karma
Received 0 Karma
Received 0 Karma






+
Thanks Mark! Great stuff!
Thank you Mark, great webinar.
Fantastic webinar Mark thank you.
Join now or log in to leave a comment